Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05JAA
|
|||
| Former ID |
DNCL002414
|
|||
| Drug Name |
ARRY-382
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | Phase 2 | [1] | |
| Company |
Array BioPharma; Celgene
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Colony stimulating factor-1 receptor (CSF-1R) | Target Info | Modulator | [2] |
| Macrophage colony-stimulating factor 1 receptor (CSF1R) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | MAPK signaling pathway | |||
| Ras signaling pathway | ||||
| Rap1 signaling pathway | ||||
| Cytokine-cytokine receptor interaction | ||||
| Viral protein interaction with cytokine and cytokine receptor | ||||
| PI3K-Akt signaling pathway | ||||
| Osteoclast differentiation | ||||
| Hematopoietic cell lineage | ||||
| Pathways in cancer | ||||
| Transcriptional misregulation in cancer | ||||
| Acute myeloid leukemia | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Company report (Array) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.